Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Isosorbide dinitrate 5mg/5ml oral liquid
0206010I0AAATAT
|
Isosorbide dinitrate (Angina) | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 10mg/5ml oral liquid
0206010K0AAANAN
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 15mg/5ml oral solution
0206010K0AAASAS
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 30mg modified-release tablets
0206010K0AABDBD
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 30mg/5ml oral liquid
0206010K0AAARAR
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 40mg/5ml oral solution
0206010K0AAAMAM
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isosorbide mononitrate 60mg/5ml oral solution
0206010K0AAAWAW
|
Isosorbide mononitrate | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Isosource Energy Fibre liquid
090402000BBNQA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Isosource Energy liquid
090402000BBJCA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Isosource Fibre liquid
090402000BBJBA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Isosource Standard liquid
090402000BBIYA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Isotretinoin 20mg tablets
1306020J0AAADAD
|
Isotretinoin (Systemic) | Isotretinoin | Skin | No data available |
|
Isotrex 0.05% gel
1306010M0BBAAAA
|
Isotrex | Isotretinoin | Skin | No data available |
|
Isovorin 175mg/17.5ml solution for injection vials
0801000U0BBABAB
|
Isovorin | Calcium levofolinate | Malignant Disease and Immunosuppression | No data available |
|
Isovorin 25mg/2.5ml solution for injection vials
0801000U0BBAAAA
|
Isovorin | Calcium levofolinate | Malignant Disease and Immunosuppression | No data available |
|
Ispaghula husk 3.4g oral pdr sachets gluten free sugar free
0106010E0AAAJAJ
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 3.5g oral pdr sachets gluten free sugar free
0106010E0AAASAS
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 6g oral powder sachets gluten free sugar free
0106010E0AAAKAK
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 90% granules for oral suspension sugar free
0106010E0AAACAC
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk oral powder sugar free
0106010E0AAAVAV
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Isradipine 2.5mg tablets
0206020I0AAAAAA
|
Isradipine | Isradipine | Cardiovascular System | No data available |
|
Isteranda 1.5mg tablets
0703050A0BEAAAB
|
Isteranda | Levonorgestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Itraconazole 250mg/25ml concentrate and solvent for inf amp
0502010C0AAADAD
|
Itraconazole | Itraconazole | Infections | No data available |
|
Ituxredi 100mg/10ml concentrate for inf vials
0802030F0BFABAB
|
Ituxredi | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Ituxredi 500mg/50ml concentrate for inf vials
0802030F0BFAAAA
|
Ituxredi | Rituximab | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.